Because our findings suggested that miR-16 might inhibit NPC cell proliferation, migration and invasion by targeting FGF2, we assessed the effects of miR-16 overexpression on the MAPK and PI3K/AKT signaling pathways to determine the mechanism by which FGF2 contributed to NPC progression. The gene discussed is AKT1; the disease is nasopharyngeal carcinoma.